Skip to main content
. 2010 Dec 8;15(12):1329–1334. doi: 10.1634/theoncologist.2010-0105

Table 2.

Sustained corticosteroid reduction by response and PFSa

graphic file with name onc01210-0706-t02.jpg

aPercentages are based on response and PFS status of only those patients who were taking corticosteroids at baseline. Sustained reduction was defined as ≥50% corticosteroid dose reduction, relative to baseline, for ≥50% of time on study drug.

Abbreviations: BEV, bevacizumab; CPT-11, irinotecan; PFS, progression-free survival.